⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRVO News
CervoMed Inc. Common Stock
Form 8-K
sec.gov
CRVO
CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO
CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO
Form 8-K
sec.gov
CRVO
CervoMed Announces New Data at the AD/PD™ 2026 Scientific Conference that Reinforce Neflamapimod’s Positive Effects in Dementia with Lewy Bodies (DLB) in Patients without Alzheimer’s Disease Co-Pathology
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO
CervoMed Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
globenewswire.com
CRVO
CervoMed Announces Presentations at Upcoming AD/PD™ 2026 Scientific Conference
globenewswire.com
CRVO